Y.-y. Yin et al. / Journal of Fluorine Chemistry 120 (2003) 117–120
119
Table 2
Asymmetric allylation of aldehydes catalyzed by Rf-BINOL/Ti(IV) in fluorous biphase system
20
½aꢀD CHCl3
Entry
Substrate
Time (h)
Yield %
e.e.%a
1
2
4-Fluorobenzaldehyde
3-Fluorobenzaldehyde
3-Fluoro-5-trifluoromethyl-benzaldehyde
4-Chlorobenzaldehyde
4-Bromobenzaldehyde
2-Chlorobenzaldehyde
2,4-Dichlorobenzaldehyde
4-Methoxybenzaldehyde
4-Ethylbenzaldehyde
3
3
91
80.9
87.6
n.d.b
82.6
58.6
n.d.
54.0
47.0
31.4
33.9
24.0
53.8
43.9
32.1
33.9
24.5
À11.6c
38.7
86
81
3
3
4
10
12
12
12
12
24
24
24
12
51
5
12
6
83
16
7
n.d.
8
47
54.6
51.0
62.7
n.d.
9
25
21
10
11
12
4-Ethoxybenzaldehyde
Octanalaldehyde
Trace
31
3-Bromobenzaldehyde
76.0
The catalysts can be recovered by continuous extraction. Recovered ligands were used without obvious loss of activity.
a The absolute configurations were determined by comparison with reported specific rotation [10a]. The enantioselectivities were determined by chiral
HPLC.
b Not determined.
c In benzene.
(m, 5H, ArH), 6.73–6.89 (m, 1H, CH=CH2), 5.20–5.32 (m,
2H, CH=CH2), 4.70–4.78 (m, 1H, CHOH), 2.48–2.57 (m,
2H, CH2), 2.12 (s, 1H, OH).
CH=CH2), 5.11–5.19 (m, 2H, CH=CH2), 4.70 (t,
J ¼ 6:6 Hz, 1H, CHOH), 2.38–2.55 (m, 2H, CH2), 2.20
(s, 1H, OH).
20
20
(R)-1-(4-Fluorophenyl)-3-buten-1-ol ½aꢀD þ 54.0 (c, 1.1,
(R)-1-(4-Bromophenyl)-3-buten-1-ol ½aꢀD þ 24.0 (c, 3.5,
CHCl3); IR (film, cmÀ1) 3385, 2927, 1641, 1605, 1510,
1431, 1224, 1157, 1051, 836; 1H NMR (CDCl3) d 7.28–7.36
(m, 2H, ArH), 6.97–7.08 (m, 2H, ArH), 5.71–5.86 (m, 1H,
CH=CH2), 5.12–5.20 (m, 2H, CH=CH2), 4.72 (t,
J ¼ 6:6 Hz, 1H, CHOH), 2.40–2.56 (m, 2H, CH2), 2.09
(s, 1H, OH).
CHCl3); IR (film, cmÀ1) 3384, 3077, 2978, 2929, 1641,
1
1592, 1488, 1404, 1296, 1070, 1010, 918, 825; H NMR
(CDCl3) d 7.46 (dd, J1 ¼ 8:4 Hz, J2 ¼ 2:0 Hz, 2H, ArH),
7.22 (dd, J1 ¼ 8:7 Hz, J2 ¼ 2:1 Hz, 2H, ArH), 5.70–5.85
(m, 1H, CH=CH2), 5.12–5.20 (m, 2H, CH=CH2), 4.68 (t,
J ¼ 6:5 Hz), 2.38–2.52 (m, 2H, CH2), 2.22 (s, 1H, OH).
20
20
(R)-1-(3-Fluorophenyl)-3-buten-1-ol ½aꢀD þ 47.0 (c, 2.3,
(R)-1-(2-Chlorophenyl)-3-buten-1-ol ½aꢀD þ 53.8 (c, 1.1,
CHCl3); IR (film, cmÀ1) 3380, 3078, 2980, 2929, 1642, 1615,
CHCl3); IR (film, cmÀ1) 3396, 3074, 2979, 2923, 1641,
1
1
1591, 1488, 1248, 1139, 1052, 992, 920, 873; H NMR
1574, 1473, 1438, 1196, 1131, 1048, 987, 917, 872; H
(CDCl3) d 7.25–7.34 (m, 1H, ArH), 7.05–7.13 (m, 2H,
ArH), 6.91–6.99 (m, 1H, ArH), 5.70–5.85 (m, 1H, CH=CH2),
5.12–5.20 (m, 2H, CH=CH2), 4.70 (t, J ¼ 6:3 Hz, 1H,
CHOH), 2.38–2.57 (m, 2H, CH2), 2.25 (s, 1H, OH).
(R)-1-(3-Fluoro-5-trifluoromethylphenyl)-3-buten-1-ol
NMR (CDCl3) d 7.56 (dd, J1 ¼ 7:5 Hz, J2 ¼ 1:5 Hz, 1H,
ArH), 7.17–7.35 (m, 3H, ArH), 5.80–5.97 (m, 1H,
CH=CH2), 5.15–5.26 (m, 3H,), 2.58–2.69 (m, 1H), 2.32–
2.42 (m, 1H), 2.21 (s, 1H, OH).
20
(R)-1-(2, 4-Dichlorophenyl)-3-buten-1-ol ½aꢀD þ 43.9 (c,
20
½aꢀD þ 31.4 (c, 1.6, CHCl3); IR (film, cmÀ1) 3392, 3084,
3.2, CHCl3); IR (KBr, cmÀ1) 3382, 2999, 2939, 1639, 1590,
1470, 1220, 1070, 927, 823; 1H NMR (CDCl3) d 7.25–7.53
(m, 3H, ArH), 5.75–5.92 (m, 1H, CH=CH2), 5.07–5.22 (m,
3H,), 2.56–2.67 (m, 1H), 2.27–2.39 (m, 1H), 2.21 (s, 1H, OH).
2983, 2916, 1643, 1607, 1455, 1344, 1229, 1172, 1092,
1
1055, 924, 877; H NMR (CDCl3) d 7.25–7.53 (M, 3H,
ArH), 5.72–5.86 (m, 1H, CH=CH2), 5.15–5.24 (m, 2H,
CH=CH2), 4.80 (t, J ¼ 6:3 Hz), 2.38–2.51 (m, 2H, CH2),
2.20 (s, 1H, OH).
20
(R)-1-(4-Methyloxyphenyl)-3-buten-1-ol ½aꢀD þ 32.1 (c,
2.5, CHCl3); IR (film, cmÀ1) 3398, 2931, 2836, 1639, 1612,
1513, 1302, 1175, 1036, 916, 832; 1H NMR (CDCl3) d 7.24
(dd, J1 ¼ 8:7 Hz, J2 ¼ 2:0 Hz,.2H, ArH), 6.89 (dt,
J1 ¼ 8:4 Hz, J2 ¼ 2:4 Hz,.2H, ArH), 5.71–5.86 (m, 1H,
CH=CH2), 5.07–5.18 (m, 2H, CH=CH2), 4.68 (t, J ¼
20
(R)-1-(4-Chlorophenyl)-3-buten-1-ol ½aꢀD þ 33.9 (c, 1.1,
CHCl3); IR (film, cmÀ1) 3377, 3078, 2979, 2928, 1641,
1
1596, 1492, 1411, 1091, 1050, 919, 870, 829; H NMR
(CDCl3) d 7.25–7.34 (m, 4H, ArH), 5.70–5.84 (m, 1H,
Scheme 2. Asymmetric allylation of aldehyde promoted by Rf-BINOLs in FBS.